Home News Ag Economics FDA Will Not Conduct Broad Sampling of Salinas Valley Leafy Greens in 2022

FDA Will Not Conduct Broad Sampling of Salinas Valley Leafy Greens in 2022

The U.S. Food and Drug Administration will not conduct broad sampling of leafy greens grown in the Salinas Valley region of California for the 2022 growing season.

The decision was made based on data from Western Growers, the California Leafy Greens Marketing Agreement, and the California Department of Food and Agriculture inspection activities.

The FDA encouraged the organizations to continue to work with the agency to enhance the sharing of industry information on pre-harvest and post-harvest testing as all parties aim to assure the safety of leafy greens.

“Western Growers is committed to developing and deploying data collection and analytic digital tools to further enhance the sharing of industry information,” said De Ann Davis, WG’s Senior Vice President of Science. “We think this is an encouraging development for our members as we strive to grow the safest produce possible.”

The FDA notes they are considering risk-based surveillance sampling based on historical data and information from previous outbreaks of foodborne illness and reserves the right to reassess this approach if unforeseen events occur.

Leave a Reply

Your email address will not be published.